For NPs and PAs: Caring for Every Breath

Share and receive information and clinical insights with other nurse-practitioners and physician's assistants.

 

XOPENEX for Bronchospasm

XOPENEX Inhalation Solution delivered first-dose efficacy in children

Immediately postdose, significantly more patients responded to the lowest dose of XOPENEX Inhalation Solution (0.31 mg) than to racemic albuterol 1.25 mg (P=.012)

Indication: XOPENEX Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.

Important Safety Information: Due to the cardiovascular side effects associated with β-agonists, caution is generally recommended for patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension), diabetes, hyperthyroidism, or convulsive disorders.

 

Efficacy started with a strong response

More pediatric patients achieved peak increases in FEV1 of ≥15% from visit predose averaged over the double-blind period

Indication: XOPENEX HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.

 

XOPENEX Inhalation Solution delivered significant improvement in moderate-to-severe asthma patients

Indication: XOPENEX HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.

 

Why Choose XOPENEX for My Patients?

XOPENEX brand of levalbuterol provides proven efficacy and safety in adult and pediatric patients with asthma and adults with chronic obstructive pulmonary disease (COPD).

XOPENEX HFA and XOPENEX Inhalation Solution have demonstrated proven efficacy and safety as seen in several pivotal clinical trials 1,2,3


References:
1. Nelson HS et al. J Allergy Clin Immunol. 1998;102:943-952
2. Milgrom H et al. J Allergy Clin Immunol. 2001;108:938-945
3. Berger WE et al. Curr Med Res Opin. 2006;22:1217-1226.

There is a Difference

Albuterol is a 50:50 mix of both the (S)-isomer and the (R)-isomer. XOPENEX contains only the single (R)-isomer, also known as levalbuterol. The (R)-isomer is known to be the isomer responsible for the bronchodilation provided by albuterol.

 

 
 

Sepracor

 

You are now leaving the XOPENEX website. Sepracor is not responsible for the information contained in any of the linked sites.